Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
Jessica A LakeAndrew M DonsonEric PrinceKurtis D DaviesAnandani NellanAdam L GreenJean Mulcahy LevyKathleen DorrisRajeev VibhakarTodd C HankinsonNicholas K ForemanMark D EwaltBette K Kleinschmidt-DeMastersLindsey M HoffmanAhmed GilaniPublished in: Pediatric blood & cancer (2019)
Fusion testing proved to be informative in a high percentage of cases. A large majority of fusion events in pediatric glial, glioneuronal, and ependymal tumors can be identified by relatively small gene panels.